Document is current
Any future updates will be listed below
-
Authors
Gabrielli, François
Zuel, Melissa
Magaud, Camille
Sickout-Arondo, Sophia
Pereira, Bruno
Dassa, Jérémie
De Gaalon, Solène
Demarquay, Geneviève
Donnet, Anne
Ducros, Anne
Giraud, Pierric
Guégan-Massardier, Evelyne
Lucas, Christian
Mawet, Jérôme
Najjar, Mitra
Roos, Caroline
Van Obberghen, Elise K.
Dualé, Christian
Dallel, Radhouane
Moisset, Xavier
- License Information
-
More Information
Article History
Received: 20 March 2025
Accepted: 6 May 2025
First Online: 26 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: F Gabrielli has nothing to disclose. M Zuel has nothing to disclose in relation to this study. C Magaud currently works for PPD, Part of Thermo Fisher Scientific. Sophia Sickout Arondo received travel, accommodation, and meeting expenses from SOS oxygen and Vertex. B Pereira has nothing to disclose. J Dassa has nothing to disclose in relation to this study. S De Gaalon has nothing to disclose in relation to this study. G Demarquay has received financial support from Allergan-Abbvie, Lilly, Lundbeck, Novartis, Pfizer and Teva not related to the submitted work. A Donnet reports fees from Allergan/Abbvie, Lilly, Lundbeck, Novartis, Orion pharma, Perfood, Pfizer, Teva, not related to the submitted work. A Ducros has nothing to disclose in relation to this study. P Giraud has received financial support from Allergan-Abbvie, Lundbeck, Merck-Serono, Pfizer, Roche and Sanofi. E Guégan-Massardier has received financial support from Allergan-Abbvie, Boehringer Ingelheim, Lilly, Lundbeck, Teva, Medtronic, Novartis, Pfizer not related to the submitted work. C Lucas has received financial support from Abbvie, Lilly, Lundbeck, Orion pharma, Pfizer and Teva, not related to the submitted work. J Mawet reports fees from Abbvie, Lilly, Lundbeck, Orion pharma, Pfizer, Teva and non-financial support from Dr Reddy’s, Ipsen pharmaceutical and SOS Oxygène, not related to the submitted work. M Najjar has nothing to disclose in relation to this study. C Roos has nothing to disclose in relation to this study. EK Van Obberghen has nothing to disclose in relation to this study. C Dualé has nothing to disclose. R Dallel has nothing to disclose. X Moisset has received financial support from Allergan-Abbvie, Amgen, Aptis Pharma, Biogen, Lilly, Lundbeck, Teva, Merck-Serono, Novartis, Orion pharma, Pfizer, Roche, and Sanofi-Aventis and non-financial support from Dr Reddy’s, Elivie, SOS Oxygène and Vertex, not related to the submitted work.
